Kaia Health has just announced a $75 million funding round for its technology, aimed at improving musculoskeletal (MSK) and chronic obstructive pulmonary disease (COPD) care.
With recent market changes catalysing a rapid shift to an omnichannel approach, life science organisations of every size are racing to adapt their commercial approach to be more relevant, c
Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights and innovations and is accelerating the development of new and innovative therap